Discovery of a Small‐Molecule pBcl‐2 Inhibitor that Overcomes pBcl‐2‐Mediated Resistance to Apoptosis
Discovery of a Small‐Molecule pBcl‐2 Inhibitor that Overcomes pBcl‐2‐Mediated Resistance to Apoptosis
复制标题
DOI:
10.1002/cbic.201402639
复制
发表时间:
2015-03
期刊:
影响因子:
3.2
通讯作者:
T. Song;Xiaoyan Yu;Yubo Liu;Xiangqian Li;G. Chai;Zhichao Zhang
中科院分区:
文献类型:
--
作者:
T. Song;Xiaoyan Yu;Yubo Liu;Xiangqian Li;G. Chai;Zhichao Zhang
Although the role of Bcl‐2 phosphorylation is still under debate, it has been identified in a resistance mechanism to BH3 mimetics, for example ABT‐737 and S1. We identified an S1 analogue, S1‐16, as a small‐molecule inhibitor of pBcl‐2. S1‐16 efficiently kills EEE‐Bcl‐2 (a T69E, S70E, and S87E mutant mimicking phosphorylation)‐expressing HL‐60 cells and high endogenously expressing pBcl‐2 cells, by disrupting EEE‐Bcl‐2 or native pBcl‐2 interactions with Bax and Bak, followed by apoptosis. In vitro binding assays showed that S1‐16 binds to the BH3 binding groove of EEE‐Bcl‐2 (Kd=0.38 μM by ITC; IC50=0.16 μM by ELISA), as well as nonphosphorylated Bcl‐2 (npBcl‐2; Kd=0.38 μM; IC50=0.12 μM). However, ABT‐737 and S1 had much weaker affinities to EEE‐Bcl‐2 (IC50=1.43 and >10 μM, respectively), compared with npBcl‐2 (IC50=0.011 and 0.74 μM, respectively). The allosteric effect on BH3 binding groove by Bcl‐2 phosphorylation in the loop region was illustrated for the first time.